Name
Osaühing Kose-Lasnamäe Perearstikeskus
Registry code
10811998
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
02.11.2001 (23)
Financial year
01.01-31.12
Capital
2 682.00 €
Activity
86211 - Provision of general medical treatment
809 956 €
94 609 €
12%
3 433 €
(estimate is approximate)
292 196 €
8
Submitted
No tax arrears
32%
25%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ruth Puusepp 29.06.1971 (53) | 50% - 1 341.00 EUR | Board member | - | |
| Tiina Vendik 03.06.1960 (64) | 50% - 1 341.00 EUR | Board member | - | |
| Projektijuht Aare OÜ 10613420 | - | - | - | Founder |
| 2019 26.03.2021 | 2020 06.06.2022 | 2021 08.05.2023 | 2022 11.09.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 589 344 € | 413 427 € | 597 685 € | 610 824 € | 809 956 € |
| Net profit (loss) for the period | 68 920 € | -78 103 € | 42 859 € | -18 438 € | 94 609 € |
| Profit Margin | 12% | -19% | 7% | -3% | 12% |
| Current Assets | 309 606 € | 234 072 € | 346 758 € | 309 967 € | 382 451 € |
| Fixed Assets | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 309 606 € | 234 072 € | 346 758 € | 309 967 € | 382 451 € |
| Current Liabilities | 58 336 € | 60 905 € | 130 732 € | 112 380 € | 90 255 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 251 270 € | 173 167 € | 216 026 € | 197 587 € | 292 196 € |
| Employees | 7 | 8 | 8 | 8 | 8 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 44 003.04 € | 46 679.74 € | 8 |
| 2023 Q4 | - | 37 721.44 € | 40 018.49 € | 8 |
| 2023 Q3 | - | 51 583.95 € | 54 666.67 € | 8 |
| 2023 Q2 | - | 37 296.79 € | 39 555.74 € | 8 |
| 2023 Q1 | - | 38 090.81 € | 40 401.93 € | 10 |
| 2022 Q4 | - | 35 830.86 € | 38 025.51 € | 10 |
| 2022 Q3 | - | 49 955.4 € | 52 893.64 € | 10 |
| 2022 Q2 | - | 32 200.11 € | 34 107.1 € | 9 |
| 2022 Q1 | - | 37 745.09 € | 39 936.44 € | 9 |
| 2021 Q4 | - | 40 764.36 € | 43 166.87 € | 9 |
| 2021 Q3 | - | 32 755.43 € | 35 049.43 € | 9 |
| 2021 Q2 | - | 36 133.17 € | 38 641.4 € | 9 |
| 2021 Q1 | - | 32 526.6 € | 34 783.29 € | 9 |
| 2020 Q4 | - | 25 993.97 € | 27 932.86 € | 9 |
| 2020 Q3 | - | 38 231.75 € | 41 113.85 € | 8 |
| 2020 Q2 | - | 25 812.83 € | 27 767.98 € | 8 |
| 2020 Q1 | - | 28 125.08 € | 30 313.06 € | 8 |
